Avidity Biosciences Inc (RNA)
25.10
-0.04
(-0.16%)
USD |
NASDAQ |
Apr 24, 16:00
25.10
0.00 (0.00%)
After-Hours: 20:00
Avidity Biosciences Shareholders Equity (Quarterly): 500.76M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 500.76M |
| September 30, 2023 | 517.47M |
| June 30, 2023 | 559.18M |
| March 31, 2023 | 558.92M |
| December 31, 2022 | 578.08M |
| September 30, 2022 | 376.98M |
| June 30, 2022 | 374.35M |
| March 31, 2022 | 375.71M |
| December 31, 2021 | 381.43M |
| Date | Value |
|---|---|
| September 30, 2021 | 394.88M |
| June 30, 2021 | 264.48M |
| March 31, 2021 | 286.12M |
| December 31, 2020 | 306.22M |
| September 30, 2020 | 320.16M |
| June 30, 2020 | 330.30M |
| March 31, 2020 | 66.00M |
| December 31, 2019 | -65.36M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-65.36M
Minimum
Dec 2019
578.08M
Maximum
Dec 2022
360.33M
Average
375.71M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | -346.30M |
| Codexis Inc | 86.62M |
| HOOKIPA Pharma Inc | 89.86M |
| Dyne Therapeutics Inc | 91.29M |
| Kineta Inc | 2.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 628.56M |
| Total Liabilities (Quarterly) | 127.79M |
| Current Ratio | 7.577 |